Stock Analiz

Glass House Brands Inc. GLAS

Medicinal Chemicals and Botanical Products · data as of November 13, 2026

$1.27Market cap $112M
Open the interactive analysis →

Glass House Brands Inc. (GLAS) is a healthcare company listed in the US with a market value of about $112M. In the twelve months to June 30, 2026 it had revenue of $177M and net income of -$68M, a net margin of -38.2%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 30% a year, a 5-year average ROIC of -13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 12% below the current price.

About Glass House Brands

Glass House Brands is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $48M in 2020 to $182M in 2025, growth of about 30.4% a year. It was profitable in 1 of the last 6 years in our data.

Score: 0.8 / 5

Value0/5
Future growth2/5
Track record1/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 5-year revenue growth above 8% a year
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.6
P/B1.5
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-33.1%
Shareholder yield0.0%
Intrinsic value vs. price−12%

Growth and quality

Revenue growth (1 yr)-9.4%
Revenue growth (5 yrs, per year)30.4%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-36.8%
ROIC (5-yr avg.)-12.7%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 6 years

Fiscal yearTTM202520242023202220212020
Revenue$177M$182M$201M$161M$85M$63M$48M
Net income-$68M-$30M$519000-$98M-$33M-$43M-$17M
Free cash flow-$37M-$16M$18M$11M-$69M-$129M-$12M
EPS (diluted)$-0.79$-0.34$0.01$-1.12$-0.37$-0.49$-0.19
Net margin-38.2%-16.3%0.3%-61.1%-38.8%-68.2%-34.5%
ROIC—-8.9%2.5%-24.0%-20.5%-12.4%-10.6%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 3 analysts is $9.00, 609% above the current price; targets range from $7.00 to $12.00; the consensus rating is “none”; expected EPS is $-0.50 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is Glass House Brands stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 12% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Glass House Brands pay a dividend?

Not currently.

Is Glass House Brands a good stock to buy?

We do not give buy or sell advice. Glass House Brands scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.